Future research focusing on receptor-ligand interactions involved in NK cell immunosuppression including CS1-CS1, 2B4-CD48 and LLT1-NKRP1A may prove beneficial for better understanding and treatment of leukemia. This evidence concerns the gene SLAMF7 and leukemia.